Weight loss and tiny cell particles study
Part of Hormones & metabolism clinical trials.
This study looks at how weight loss from a special diet affects tiny particles in your blood, called microvesicles, that help control your body's energy use. It may help us understand why weight loss improves health for people with obesity.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age 18 to 70 years old
- Body mass index (BMI) between 27 and 40 (a measure of weight for height)
- Generally healthy, besides weight-related issues
- Willing to follow a calorie-restricted diet and not take certain medications
- Not pregnant or breastfeeding
- No recent infections, serious diseases, or eating disorders
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks at how weight loss changes tiny particles released from fat cells and whether that improves blood vessel function. It may help understand how losing weight can protect your heart.
This study tests a new medicine to see how it affects the body's energy use after losing weight. It compares the medicine to a low-calorie diet or a placebo (a pill with no active ingredient) in adults with obesity.
This trial tests a modified intermittent eating plan to help people with obesity lose weight and keep it off. It compares different eating schedules to see which works best for long-term weight control.
This study looks at how diet, appetite, and body changes work together during weight loss. It's designed for people with a BMI of 30 to 50 who want to lose weight and are not taking certain medications or have certain health conditions.
This study looks at tiny particles released from fat tissue in people with and without obesity. It aims to understand differences that might help explain obesity-related health problems.
This study looks at how very small particles in the body (“extracellular vesicles”) relate to insulin action and how the body handles sugar. It may help researchers understand why some people have better or worse insulin responses.
Hear when a new Obesity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.